Engelbert Coster Tjeenk Willink

Biography

Dr. Engelbert Coster Tjeenk Willink, also known as Bert, M.D., has been the Chairman of Executive Board and Chief Executive Officer of STADA Arzneimittel Aktiengesellschaft since July 4, 2017. Dr. Willink has more than 25 years' experience within the pharmaceutical industry. Dr. Willink served as Head of Corporate Board Division - Marketing & Sales Human Pharma at C.H. Boehringer Sohn AG & Co. KG until December 31, 2012 and served as its Member of Board of Managing Directors from December 2008 to December 2012. He was responsible for the business area Prescription Medicine and Consumer Health Care. He served as Head of Marketing for Prescription Medicines at Boehringer Ingelheim GmbH from 2001 to 2005. He served as the Head of Marketing and Sales in Canada. From 2005 to 2008, he served as Country Manager of Boehringer Ingelheim Mexico. Dr. Willink has been the Chairman of the Board at Allecra Therapeutics GmbH since April 5, 2017. Dr. Willink served as a Member of the Board of Managing Directors at Boehringer Ingelheim, Inc. (Boehringer Ingelheim Ltd., UK) from December 2008 to December 31, 2012 and Boehringer Ingelheim GmbH. 

Research Interest

 Generics